
Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer
Keywords: فاکتور رشد اندوتلیال عروقی (VEGF); NSCLC; Bevacizumab; First-line; Clinical genotyping; Biomarkers; VEGF;